BCR and B-cell non-Hodgkin lymphoma: Furthermore, B cell receptor (BCR) activation was shown to promote B cell lymphomagenesis in conjunction with Myc [15]; and using a CD19 knockout mouse model, the CD19 signaling loop was revealed to promote development and progression of B cell lymphoma [16].